In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance

Seminars in Respiratory Infections

Volumn 12, Issue 4, 1997, Pages 278-293

  Schentag, J J ^a   Birmingham, M C ^a   Paladino, J A ^a   Carr, J R ^a   Hyatt, J M ^a   Forrest, A ^a   Zimmer, G S ^a   Adelman, M H ^a   Cumbo, T J ^a  

^a Millard Fillmore Gates Circle Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; MEROPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; BACTERIAL PNEUMONIA; BACTERICIDAL ACTIVITY; CLINICAL PHARMACY; CLINICAL TRIAL; DOSE RESPONSE; DRUG COST; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CEFTAZIDIME; CLINICAL TRIALS; CROSS INFECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HUMANS; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, BACTERIAL; STAPHYLOCOCCUS; TREATMENT OUTCOME;

EID: 0031449986     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)